P Morand

ORCID: 0000-0003-0306-8759
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Antibiotic Resistance in Bacteria
  • Orthopedic Infections and Treatments
  • Mycobacterium research and diagnosis
  • Pericarditis and Cardiac Tamponade
  • Infectious Diseases and Tuberculosis
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiac tumors and thrombi
  • Cardiovascular Function and Risk Factors
  • Cystic Fibrosis Research Advances
  • Antimicrobial Resistance in Staphylococcus
  • Tuberculosis Research and Epidemiology
  • Cardiac electrophysiology and arrhythmias
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Infective Endocarditis Diagnosis and Management
  • Congenital Heart Disease Studies
  • Acne and Rosacea Treatments and Effects
  • Liver Disease Diagnosis and Treatment
  • Cardiovascular Syncope and Autonomic Disorders
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Lipoproteins and Cardiovascular Health
  • Hepatitis C virus research

Hôpital Cochin
2015-2024

Assistance Publique – Hôpitaux de Paris
2014-2024

Université Paris Cité
2012-2024

Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale
2009-2024

Institut Cochin
2009-2024

Inserm
2009-2024

Centre National de la Recherche Scientifique
2011-2024

Hôpital Broca
2016-2021

Délégation Paris 5
2010-2020

Centre Hospitalier Universitaire de Grenoble
2000-2018

Aims of this study were to: (i) evaluate whether the cluster membership could have an impact on hetero-resistance phenotype to colistin in Enterobacter cloacae complex (ECC); and (ii) determine genetic mechanism ECC.A collection 124 clinical isolates belonging 13 clusters used analyse (MICs determined using broth microdilution method, Etest population analysis profiling). Different mutants (ΔphoP, ΔphoQ, ΔphoPQ, ΔpmrA, ΔpmrB, ΔpmrAB, ΔarnE, ΔarnF ΔarnBCADTEF) constructed tested for their...

10.1093/jac/dkw260 article EN Journal of Antimicrobial Chemotherapy 2016-07-11

Propionibacterium acnes (P. acnes) is an anaerobic, Gram-positive bacteria encountered in inflammatory acne lesions, particularly the pilosebaceous follicle. P. triggers a strong immune response involving keratinocytes, sebocytes and monocytes, target cells during development. Lipoteicoic acid peptidoglycan induce reaction, but no surface protein interacting with Toll-like receptors has been identified. proteins have extracted by lithium stripping shown to CXCL8 production...

10.1371/journal.pone.0167237 article EN cc-by PLoS ONE 2016-11-30

ObjectiveBetween July 1992 and December 1994, 16 French hospital centres, mainly cardiological, participated in a non-controlled observational study on venous thromboembolic disease. The objective of this survey was to collect data concerning the current status pulmonary embolism deep thrombosis.

10.1093/oxfordjournals.eurheartj.a015316 article EN European Heart Journal 1997-04-02

Mupirocin is the cornerstone of decolonization regimens, a successful strategy to prevent healthcare-associated staphylococcal infections. Several recent studies have reported alarming results: (i) an extending reservoir mupA, ancestral mobile resistance gene, among coagulase-negative staphylococci (CoNS); (ii) emergence new gene (mupB); and (iii) growing number mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA), including highly pathogenic clones. We performed nationwide...

10.1093/jac/dkt085 article EN Journal of Antimicrobial Chemotherapy 2013-03-27

In the context of increasing antimicrobial resistance in Enterobacterales, management these UTIs has become challenging. We retrospectively assess prevalence Enterobacterales isolates recovered from urinary tract samples France, between 1 September 2017, to 31 August 2018. Twenty-six French clinical laboratories provided susceptibility 134,162 17 antimicrobials. The most frequent species were E. coli (72.0%), Klebsiella pneumoniae (9.7%), Proteus mirabilis (5.8%), and Enterobacter cloacae...

10.3390/pathogens11030356 article EN cc-by Pathogens 2022-03-15

Bacteria belonging to the Enterobacter genus are frequently isolated from clinical samples but unusual causative agents of orthopedic implant infections. Twelve genetic clusters (clusters I XII) and one sequence crowd (sequence xiii) can be distinguished within cloacae nomenspecies on basis hsp60 analysis, until now, none these could specifically associated with a disease. In order investigate if specific would involved in infections material, two series bacterial isolates identified as E....

10.1128/jcm.00290-09 article EN Journal of Clinical Microbiology 2009-06-11

Abstract Background Cutibacterium species are common pathogens in periprosthetic joint infections (PJI). These often treated with β-lactams or clindamycin as monotherapy, combination rifampin. Clinical evidence supporting the value of adding rifampin for treatment PJI is lacking. Methods In this multicenter retrospective study, we evaluated patients and a minimal follow-up 12 months. The primary endpoint was clinical success, defined by absence infection relapse new infection. We used...

10.1093/cid/ciaa1839 article EN Clinical Infectious Diseases 2020-12-08

Tigecycline is a new broad-spectrum antibiotic. Nausea and vomiting are its most common side-effects. We describe here case of severe acute pancreatitis related to tigecycline in order highlight the possible occurrence this adverse event remind clinicians measure lipase rate if any doubt.

10.1080/00365540801938949 article EN Scandinavian Journal of Infectious Diseases 2008-01-01

Pelvic bone and/or soft tissue sarcoma removal surgeries are associated with a high rate of surgical site infection (SSI). The recommended antibiotic prophylaxis (ABP) duration is 24-48 h. We aimed to assess the impact extended ABP (5 days) on SSI and describe microbiology in pelvic sarcomas.We retrospectively included all consecutive patients who underwent surgery between January 2010 June 2020.We analyzed 146 (45, 31%) or (101, 69%). Sixty (41%) developed SSI. occurred 13/28 (46.4%) group...

10.1002/jso.27271 article EN Journal of Surgical Oncology 2023-04-03

Ceftolozane-tazobactam was tested against 58 multidrug-resistant nonfermenting Gram-negative bacilli (35 Pseudomonas aeruginosa, 11 Achromobacter xylosoxydans, and 12 Stenotrophomonas maltophilia isolates) isolated from cystic fibrosis patients compared to ceftolozane alone, ceftazidime, meropenem, piperacillin-tazobactam. the most active agent P. aeruginosa but inactive A. xylosoxydans S. In time-kill experiments, ceftolozane-tazobactam had complete bactericidal activity 2/6 clinical isolates (33%).

10.1128/aac.02688-16 article EN Antimicrobial Agents and Chemotherapy 2017-01-18

This study aimed at characterizing the pharmacokinetics (PK) of oral levofloxacin in adult patients order to optimize dosing scheme and explore PK/pharmacodynamics (PD) bone joint infections (BJIs).From November 2015 December 2019, all hospitalized Cochin Hospital, treated with who had least one dosage for therapeutic drug monitoring were included. PK was described using non-linear mixed-effect modelling. In a subgroup BJIs, association between PK, MIC isolated pathogen clinical outcome...

10.1093/jac/dkac031 article EN Journal of Antimicrobial Chemotherapy 2022-01-26

We used capillary electrophoresis-single-strand conformation polymorphism (CE-SSCP) analysis of PCR-amplified 16S rRNA gene fragments for rapid identification Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli isolated from patients with cystic fibrosis (CF). Target sequences were amplified by using forward reverse primers labeled various fluorescent dyes. The PCR products denatured heating separated gel electrophoresis an automated DNA sequencer. Data analyzed GeneScan 672...

10.1128/jcm.37.10.3374-3379.1999 article EN Journal of Clinical Microbiology 1999-10-01
Coming Soon ...